Quantum-Si incorporated (NASDAQ:QSI) CFO Sells $11,990.14 in Stock

Quantum-Si incorporated (NASDAQ:QSI) CFO Jeffry R. Keyes sold 8,626 shares of the business’s stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of $1.39, for a total transaction of $11,990.14. Following the sale, the chief financial officer now directly owns 1,188,194 shares of the company’s stock, valued at approximately $1,651,589.66. This trade represents a 0.72 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Quantum-Si Trading Down 4.7 %

QSI stock opened at $1.41 on Wednesday. Quantum-Si incorporated has a 1-year low of $0.61 and a 1-year high of $5.77. The firm has a market cap of $258.23 million, a PE ratio of -2.20 and a beta of 2.75. The business’s 50-day moving average price is $1.77 and its two-hundred day moving average price is $1.49.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of QSI. Renaissance Technologies LLC boosted its position in shares of Quantum-Si by 1,211.4% during the fourth quarter. Renaissance Technologies LLC now owns 544,956 shares of the company’s stock worth $1,471,000 after buying an additional 503,400 shares during the period. XTX Topco Ltd raised its holdings in shares of Quantum-Si by 460.5% in the fourth quarter. XTX Topco Ltd now owns 245,585 shares of the company’s stock valued at $663,000 after purchasing an additional 201,773 shares during the last quarter. Two Sigma Investments LP acquired a new stake in shares of Quantum-Si in the fourth quarter valued at approximately $412,000. Geode Capital Management LLC boosted its holdings in Quantum-Si by 6.7% during the third quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after purchasing an additional 145,091 shares during the last quarter. Finally, Centiva Capital LP bought a new position in Quantum-Si in the fourth quarter valued at $387,000. Institutional investors own 39.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on QSI. HC Wainwright reissued a “buy” rating and issued a $5.50 price target on shares of Quantum-Si in a research note on Tuesday, January 14th. National Bankshares set a $3.65 target price on Quantum-Si in a report on Wednesday, March 5th. Finally, Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a research report on Wednesday, March 5th.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.